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Abstract
Numerous studies are currently underway to characterize the microbial communities inhabiting our world. These studies
aim to dramatically expand our understanding of the microbial biosphere and, more importantly, hope to reveal the secrets
of the complex symbiotic relationship between us and our commensal bacterial microflora. An important prerequisite for
such discoveries are computational tools that are able to rapidly and accurately compare large datasets generated from
complex bacterial communities to identify features that distinguish them. We present a statistical method for comparing
clinical metagenomic samples from two treatment populations on the basis of count data (e.g. as obtained through
sequencing) to detect differentially abundant features. Our method, Metastats, employs the false discovery rate to improve
specificity in high-complexity environments, and separately handles sparsely-sampled features using Fisher’s exact test.
Under a variety of simulations, we show that Metastats performs well compared to previously used methods, and
significantly outperforms other methods for features with sparse counts. We demonstrate the utility of our method on
several datasets including a 16S rRNA survey of obese and lean human gut microbiomes, COG functional profiles of infant
and mature gut microbiomes, and bacterial and viral metabolic subsystem data inferred from random sequencing of 85
metagenomes. The application of our method to the obesity dataset reveals differences between obese and lean subjects
not reported in the original study. For the COG and subsystem datasets, we provide the first statistically rigorous assessment
of the differences between these populations. The methods described in this paper are the first to address clinical
metagenomic datasets comprising samples from multiple subjects. Our methods are robust across datasets of varied
complexity and sampling level. While designed for metagenomic applications, our software can also be applied to digital
gene expression studies (e.g. SAGE). A web server implementation of our methods and freely available source code can be
found at http://metastats.cbcb.umd.edu/.
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Introduction
The increasing availability of high-throughput, inexpensive
sequencing technologies has led to the birth of a new scientific
field, metagenomics, encompassing large-scale analyses of micro-
bial communities. Broad sequencing of bacterial populations
allows us a first glimpse at the many microbes that cannot be
analyzed through traditional means (only ,1% of all bacteria can
be isolated and independently cultured with current methods [1]).
Studies of environmental samples initially focused on targeted
sequencing of individual genes, in particular the 16S subunit of
ribosomal RNA [2–5], though more recent studies take advantage
of high-throughput shotgun sequencing methods to assess not only
the taxonomic composition, but also the functional capacity of a
microbial community [6–8].
Several software tools have been developed in recent years for
comparing different environments on the basis of sequence data.
DOTUR [9], Libshuff [10], #-libshuff [11], SONs [12], MEGAN
[13], UniFrac [14], and TreeClimber [15] all focus on different
aspects of such an analysis. DOTUR clusters sequences into
operational taxonomic units (OTUs) and provides estimates of the
diversity of a microbial population thereby providing a coarse
measure for comparing different communities. SONs extends
DOTUR with a statistic for estimating the similarity between two
environments, specifically, the fraction of OTUs shared between
two communities. Libshuff and #-libshuff provide a hypothesis test
(Cramer von Mises statistics) for deciding whether two commu-
nities are different, and TreeClimber and UniFrac frame this
question in a phylogenetic context. Note that these methods aim to
assess whether, rather than how two communities differ. The
latter question is particularly important as we begin to analyze the
contribution of the microbiome to human health. Metagenomic
analysis in clinical trials will require information at individual
taxonomic levels to guide future experiments and treatments. For
example, we would like to identify bacteria whose presence or
absence contributes to human disease and develop antibiotic or
probiotic treatments. This question was first addressed by
Rodriguez-Brito et al. [16], who use bootstrapping to estimate
the p-value associated with differences between the abundance of
biological subsytems. More recently, the software MEGAN of
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compare the taxonomic composition of different environments.
Note that MEGAN is the only one among the programs
mentioned above that can be applied to data other than that
obtained from 16S rRNA surveys.
These tools share one common limitation — they are all
designed for comparing exactly two samples — therefore have
limited applicability in a clinical setting where the goal is to
compare two (or more) treatment populations each comprising
multiple samples. In this paper, we describe a rigorous statistical
approach for detecting differentially abundant features (taxa,
pathways, subsystems, etc.) between clinical metagenomic datasets.
This method is applicable to both high-throughput metagenomic
data and to 16S rRNA surveys. Our approach extends statistical
methods originally developed for microarray analysis. Specifically,
we adapt these methods to discrete count data and correct for
sparse counts. Our research was motivated by the increasing focus
of metagenomic projects on clinical applications (e.g. Human
Microbiome Project [17]).
Note that a similar problem has been addressed in the context of
digital gene expression studies (e.g. SAGE [18]). Lu et al. [19]
employ an overdispersed log-linear model and Robinson and
Smyth [20] use a negative binomial distribution in the analysis of
multiple SAGE libraries. Both approaches can be applied to
metagenomic datasets. We compare our tool to these prior
methodologies through comprehensive simulations, and demon-
strate the performance of our approach by analyzing publicly
available datasets, including 16S surveys of human gut microbiota
and random sequencing-based functional surveys of infant and
mature gut microbiomes and microbial and viral metagenomes.
The methods described in this paper have been implemented as a
web server and are also available as free source-code (in R) from
http://metastats.cbcb.umd.edu.
Materials and Methods
Our approach relies on the following assumptions: (i) we are
given data corresponding to two treatment populations (e.g. sick
and healthy human gut communities, or individuals exposed to
different treatments) each consisting of multiple individuals (or
samples); (ii) for each sample we are provided with count data
representing the relative abundance of specific features within each
sample, e.g. number of 16S rRNA clones assigned to a specific
taxon, or number of shotgun reads mapped to a specific biological
pathway or subsystem (see below how such information can be
generated using currently available software packages). Our goal is
to identify individual features in such datasets that distinguish
between the two populations, i.e. features whose abundance in the
two populations is different. Furthermore, we develop a statistical
measure of confidence in the observed differences.
The input to our method can be represented as a Feature
Abundance Matrix whose rows correspond to specific features, and
whose columns correspond to individual metagenomic samples.
The cell in the i
th row and j
th column is the total number of
observations of feature i in sample j (Figure 1). Every distinct
observation is represented only once in the matrix, i.e. overlapping
features are not allowed (the rows correspond to a partition of the
set of sequences).
Data normalization
To account for different levels of sampling across multiple
individuals, we convert the raw abundance measure to a fraction
representing the relative contribution of each feature to each of the
individuals. This results in a normalized version of the matrix
described above, where the cell in the i
th row and the j
th column
(which we shall denote fij) is the proportion of taxon i observed in
individual j. We chose this simple normalization procedure
because it provides a natural representation of the count data as
a relative abundance measure, however other normalization
approaches can be used to ensure observed counts are comparable
across samples, and we are currently evaluating several such
approaches.
Analysis of differential abundance
For each feature i, we compare its abundance across the two
treatment populations by computing a two-sample t statistic.
Specifically, we calculate the mean proportion xit, and variance s2
it
of each treatment t from which nt subjects (columns in the matrix)
were sampled:
Figure 1. Format of the feature abundance matrix. Each row
represents a specific taxon, while each column represents a subject or
replicate. The frequency of the i
th feature in the j
th subject (c(i,j))i s
recorded in the corresponding cell of the matrix. If there are g subjects
in the first population, they are represented by the first g columns of
the matrix, while the remaining columns represent subjects from the
second population.
doi:10.1371/journal.pcbi.1000352.g001
Author Summary
The emerging field of metagenomics aims to understand
the structure and function of microbial communities solely
through DNA analysis. Current metagenomics studies
comparing communities resemble large-scale clinical trials
with multiple subjects from two general populations (e.g.
sick and healthy). To improve analyses of this type of
experimental data, we developed a statistical methodolo-
gy for detecting differentially abundant features between
microbial communities, that is, features that are enriched
or depleted in one population versus another. We show
our methods are applicable to various metagenomic data
ranging from taxonomic information to functional anno-
tations. We also provide an assessment of taxonomic
differences in gut microbiota between lean and obese
humans, as well as differences between the functional
capacities of mature and infant gut microbiomes, and
those of microbial and viral metagenomes. Our methods
are the first to statistically address differential abundance
in comparative metagenomics studies with multiple
subjects, and we hope will give researchers a more
complete picture of how exactly two environments differ.
Differential Abundance in Clinical Metagenomics
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Features whose t statistics exceeds a specified threshold can be
inferred to be differentially abundant across the two treatments
(two-sided t-test).
Assessing significance
The threshold for the t statistic is chosen such as to minimize the
number of false positives (features incorrectly determined to be
differentially abundant). Specifically, we try to control the p-
value—the likelihood of observing a given t statistic by chance.
Traditional analyses compute the p-value using the t distribution
with an appropriate number of degrees of freedom. However, an
implicit assumption of this procedure is that the underlying
distribution is normal. We do not make this assumption, but rather
estimate the null distribution of ti non-parametrically using a
permutation method as described in Storey and Tibshirani [21].
This procedure, also known as the nonparametric t-test has been
shown to provide accurate estimates of significance when the
underlying distributions are non-normal [22,23]. Specifically, we
randomly permute the treatment labels of the columns of the
abundance matrix and recalculate the t statistics. Note that the
permutation maintains that there are n1 replicates for treatment 1
and n2 replicates for treatment 2. Repeating this procedure for B
trials, we obtain B sets of t statistics: t1
0b,… ,tM
0b, b=1, …, B,
where M is the number of rows in the matrix. For each row
(feature), the p-value associated with the observed t statistic is
calculated as the fraction of permuted tests with a t statistic greater
than or equal to the observed ti:
pi~
# t0b
i
       § ti jj ,b~1,...,B
  
B
:
This approach is inadequate for small sample sizes in which there
are a limited number of possible permutations of all columns. As a
heuristic, if less than 8 subjects are used in either treatment, we
pool all permuted t statistics together into one null distribution and
estimate p-values as:
pi~
1
BM
X B
b~1
# j : t0b
j
     
     § ti jj , j~1,...,M
no
:
Note that the choice of 8 for the cutoff is simply heuristic based
on experiments during the implementation of our method. Our
approach is specifically targeted at datasets comprising multiple
subjects — for small data-sets approaches such as that proposed by
Rodriguez-Brito et. al. [16] might be more appropriate.
Unless explicitly stated, all experiments described below used
1000 permutations. In general, the number of permutations
should be chosen as a function of the significance threshold used in
the experiment. Specifically, a permutation test with B permuta-
tions can only estimate p-values as low as 1/B (in our case 10
23).
In datasets containing many features, larger numbers of
permutations are necessary to account for multiple hypothesis
testing issues (further corrections for this case are discussed below).
Precision of the p-value calculations is obviously improved by
increasing the number of permutations used to approximate the
null distribution, at a cost, however, of increased computational
time. For certain distributions, small p-values can be efficiently
estimated using a technique called importance sampling. Specif-
ically, the permutation test is targeted to the tail of the distribution
being estimated, leading to a reduction in the number of
permutations necessary of up to 95% [24,25]. We intend to
implement such an approach in future versions of our software.
Multiple hypothesis testing correction
For complex environments (many features/taxa/subsystems),
the direct application of the t statistic as described can lead to large
numbers of false positives. For example, choosing a p-value
threshold of 0.05 would result in 50 false positives in a dataset
comprising 1000 organisms. An intuitive correction involves
decreasing the p-value cutoff proportional to the number of tests
performed (a Bonferroni correction), thereby reducing the number
of false positives. This approach, however, can be too conservative
when a large number of tests are performed [21].
An alternative approach aims to control the false discovery rate
(FDR), which is defined as the proportion of false positives within
the set of predictions [26], in contrast to the false positive rate
defined as the proportion of false positives within the entire set of
tests. In this context, the significance of a test is measured by a q-
value, an individual measure of the FDR for each test.
We compute the q-values using the following algorithm, based
on Storey and Tibshirani [21]. This method assumes that the p-
values of truly null tests are uniformly distributed, assumption that
holds for the methods used in Metastats. Given an ordered list of
p-values, p(1)#p(2)#…#p(m), (where m is the total number of
features), and a range of values l=0, 0.01, 0.02, …, 0.90, we
compute
^ p p0 l ðÞ ~
# pjwl
  
m 1{l ðÞ
:
Next, we fit ^ p p0 l ðÞwith a cubic spline with 3 degrees of freedom,
which we denote ^ f f, and let ^ p p0~^ f f 1 ðÞ . Finally, we estimate the q-
value corresponding to each ordered p-value. First,
^ q qp m ðÞ
  
~min p m ðÞ |^ p p0,1
  
. Then for i=m-1, m-2, …, 1,
^ q qp i ðÞ
  
~min
^ p p0|m|p i ðÞ
i
, ^ q qp iz1 ðÞ
     
:
Thus, the hypothesis test with p-value p i ðÞhas a corresponding q-
value of ^ q qp i ðÞ
  
. Note that this method yields conservative
estimates of the true q-values, i.e. ^ q qp i ðÞ
  
§qp i ðÞ
  
. Our software
provides users with the option to use either p-value or q-value
thresholds, irrespective of the complexity of the data.
Handling sparse counts
For low frequency features, e.g. low abundance taxa, the
nonparametric t–test described above is not accurate [27]. We
performed several simulations (data not shown) to determine the
limitations of the nonparametric t-test for sparsely-sampled
features. Correspondingly, our software only applies the test if
Differential Abundance in Clinical Metagenomics
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greater than the total number of subjects in the population (i.e. the
average across subjects of the number of observations for a given
feature is greater than one). We compare the differential
abundance of sparsely-sampled (rare) features using Fisher’s exact
test. Fisher’s exact test models the sampling process according to a
hypergeometric distribution (sampling without replacement). The
frequencies of sparse features within the abundance matrix are
pooled to create a 262 contingency table (Figure 2), which acts as
input for a two-tailed test. Using the notation from Figure 2, the
null hypergeometric probability of observing a 262 contingency
table is:
p~
R1
f11
  
R2
f21
  
n
C1
  , where
R1~f11zf12,
R1~f21zf22,
C1~f11zf21,
n~f11zf12zf21zf22:
By calculating this probability for a given table, and all tables
more extreme than that observed, one can calculate the exact
probability of obtaining the original table by chance assuming that
the null hypothesis (i.e. no differential abundance) is true [27].
Note that an alternative approach to handling sparse features is
proposed in microarray literature. The Significance Analysis of
Microarrays (SAM) method [28] addresses low levels of expression
using a modified t statistic. We chose to use Fisher’s exact test due
to the discrete nature of our data, and because prior studies
performed in the context of digital gene expression indicate
Fisher’s test to be effective for detection of differential abundance
[29].
Creating the Feature Abundance Matrix
The input to our method, the Feature Abundance Matrix, can
be easily constructed from both 16S rRNA and random shotgun
data using available software packages. Specifically for 16S
taxonomic analysis, tools such as the RDP Bayesian classifier
[30] and Greengenes SimRank [31] output easily-parseable
information regarding the abundance of each taxonomic unit
present in a sample. As a complementary, unsupervised approach,
16S sequences can be clustered with DOTUR [9] into operational
taxonomic units (OTUs). Abundance data can be easily extracted
from the ‘‘*.list’’ file detailing which sequences are members of the
same OTU. Shotgun data can be functionally or taxonomically
classified using MEGAN [13], CARMA [32], or MG-RAST [33].
MEGAN and CARMA are both capable of outputting lists of
sequences assigned to a taxonomy or functional group. MG-RAST
provides similar information for metabolic subsystems that can be
downloaded as a tab-delimited file.
All data-types described above can be easily converted into a
Feature Abundance Matrix suitable as input to our method. In the
future we also plan to provide converters for data generated by
commonly-used analysis tools.
Data used in this paper
Human gut 16S rRNA sequences were prepared as described in
Eckburg et al. and Ley et al. (2006) and are available in GenBank,
accession numbers: DQ793220-DQ802819, DQ803048,
DQ803139-DQ810181, DQ823640-DQ825343, AY974810-
AY986384. In our experiments we assigned all 16S sequences to
taxa using a naı ¨ve Bayesian classifier currently employed by the
Ribosomal Database Project II (RDP) [30]. COG profiles of 13
human gut microbiomes were obtained from the supplementary
material of Kurokawa et al. [34]. We acquired metabolic
functional profiles of 85 metagenomes from the online supple-
mentary materials of Dinsdale et al. (2008) (http://www.theseed.
org/DinsdaleSupplementalMaterial/).
Results
Comparison with other statistical methods
As outlined in the introduction, statistical packages developed
for the analysis of SAGE data are also applicable to metagenomic
datasets. In order to validate our method, we first designed
simulations and compared the results of Metastats to Student’s t-
test (with pooled variances) and two methods used for SAGE data:
a log-linear model (Log-t) by Lu et al. [19], and a negative binomial
(NB) model developed by Robinson and Smyth [20].
We designed a metagenomic simulation study in which ten
subjects are drawn from two groups - the sampling depth of each
subject was determined by random sampling from a uniform
distribution between 200 and 1000 (these depths are reasonable
for metagenomic studies). Given a population mean proportion p
and a dispersion value w, we sample sequences from a beta-
binomial distribution B(a,b), where a=p(1/w21) and b=(12p)(1/
w21). Note that data from this sampling procedure fits the
assumptions for Lu et al. as well as Robinson and Smyth and
therefore we expect them to do well under these conditions. Lu et
al. designed a similar study for SAGE data, however, for each
simulation, a fixed dispersion was used for both populations and
the dispersion estimates were remarkably small (w=0, 8e-06, 2e-
05, 4.3e-05). Though these values may be reasonable for SAGE
data, we found that they do not accurately model metagenomic
data. Figure 3 displays estimated dispersions within each
population for all features of the metagenomic datasets examined
below. Dispersion estimates range from 1e-07 to 0.17, and rarely
do the two populations share a common dispersion. Thus we
designed our simulation so that w is chosen for each population
randomly from a uniform distribution between 1e-08 and 0.05,
allowing for potential significant differences between population
distributions. For each set of parameters, we simulated 1000
feature counts, 500 of which are generated under p1=p2, the
remainder are differentially abundant where a*p1=p2, and
compared the performance of each method using receiver-
operating-characteristic (ROC) curves. Figure 4 displays the
ROC results for a range of values for p and a. For each set of
Figure 2. Detecting differential abundance for sparse features.
A2 62 contingency table is used in Fisher’s exact test for differential
abundance between rare features. f11 is the number of observations of
feature i in all individuals from treatment 1. f21 is the number of
observations that are not feature i in all individuals from treatment 1. f12
and f22 are similarly defined for treatment 2.
doi:10.1371/journal.pcbi.1000352.g002
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compute p-values. Metastats performs as well as other methods,
and in some cases is preferable. We also found that in most cases
our method was more sensitive than the negative binomial model,
which performed poorly for high abundance features.
Our next simulation sought to examine the accuracy of each
method under extreme sparse sampling. As shown in the datasets
below, it is often the case that a feature may not have any
observations in one population, and so it is essential to employ a
statistical method that can address this frequent characteristic of
metagenomic data. Under the same assumptions as the simulation
above, we tested a=0 and 0.01, thereby significantly reducing
observations of a feature in one of the populations. The ROC
curves presented in Figure 5 reveal that Metastats outperforms
other statistical methods in the face of extreme sparseness. Holding
the false positive rate (x-axis) constant, Metastats shows increased
sensitivity over all other methods. The poor performance of Log-t
is noteworthy given it is designed for SAGE data that is also
potentially sparse. Further investigation revealed that the Log-t
method results in a highly inflated dispersion value if there are no
observations in one population, thereby reducing the estimated
significance of the test.
Finally, we selected a subset of the Dinsdale et al. [6]
metagenomic subsystem data (described below), and randomly
assigned each subject to one of two populations (20 subjects per
population). All subjects were actually from the same population
(microbial metagenomes), thus the null hypothesis is true for each
feature tested (no feature is differentially abundant). We ran each
methodology on this data, recording computed p-values for each
feature. Repeating this procedure 200 times, we simulated tests of
5200 null features. Table 1 displays the number of false positives
incurred by each methodology given different p-value thresholds.
The results indicate that the negative binomial model results in an
exceptionally high number of false positives relative to the other
methodologies. Student’s t-test and Metastats perform equally well
in estimating the significance of these null features, while Log-t
performs slightly better.
These studies show that Metastats consistently performs as well
as all other applicable methodologies for deeply-sampled features,
and outperforms these methodologies on sparse data. Below we
further evaluate the performance of Metastats on several real
metagenomic datasets.
Taxa associated with human obesity
In a recent study, Ley et al. [35] identified gut microbes
associated with obesity in humans and concluded that obesity has
a microbial element, specifically that Firmicutes and Bacteroidetes
are bacterial divisions differentially abundant between lean and
obese humans. Obese subjects had a significantly higher relative
abundance of Firmicutes and a lower relative abundance of
Bacteriodetes than the lean subjects. Furthermore, obese subjects
were placed on a calorie-restricted diet for one year, after which
the subjects’ gut microbiota more closely resembled that of the
lean individuals.
We obtained the 20,609 16S rRNA genes sequenced in Ley et al.
and assigned them to taxa at different levels of resolution (note that
2,261 of the 16S sequences came from a previous study [36]). We
initially sought to re-establish the primary result from this paper
using our methodology. Table 2 illustrates that our method agreed
with the results of the original study: Firmicutes are significantly
more abundant in obese subjects (P=0.003) and Bacteroidetes are
significantly more abundant in the lean population (P,0.001).
Furthermore, our method also detected Actinobacteria to be
differentially abundant, a result not reported by the original study.
Approximately 5% of the sample was composed of Actinobacteria
in obese subjects and was significantly less frequent in lean subjects
(P=0.004). Collinsella and Eggerthella were the most prevalent
Actinobacterial genera observed, both of which were overabun-
dant in obese subjects. These organisms are known to ferment
sugars into various fatty acids [37], further strengthening a possible
connection to obesity. Note that the original study used Students t-
test, leading to a p-value for the observed difference within
Actinobacteria of 0.037, 9 times larger than our calculation. This
Figure 3. Dispersion estimates (w) for three metagenomic
datasets used in this study. These plots compare dispersion values
between (A) obese and lean human gut taxonomic data, (B) infant and
mature human gut COG assignments, and (C) microbial and viral
subsystem annotations. We find a wide range of possible dispersions in
this data and significant differences in dispersions between two
populations.
doi:10.1371/journal.pcbi.1000352.g003
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difference was not originally detected.
To explore whether we could refine the broad conclusions of the
initial study, we re-analyzed the data at more detailed taxonomic
levels. We identified three classes of organisms that were
differentially abundant: Clostridia (P=0.005), Bacteroidetes
(P,0.001), and Actinobacteria (P=0.003). These three were the
dominant members of the corresponding phyla (Firmicutes,
Bacteroides, Actinobacteria, respectively) and followed the same
distribution as observed at a coarser level. Metastats also detected
nine differentially abundant genera accounting for more than 25%
of the 16S sequences sampled in both populations (P#0.01).
Syntrophococcus, Ruminococcus, and Collinsella were all enriched in
obese subjects, while Bacteroides on average were eight times more
abundant in lean subjects.
For taxa with several observations in each subject, we found
good concordance between our results (p-value estimates) and
those obtained with most of the other methods (Table 2).
Surprisingly, we found that the negative binomial model of
Robinson and Smyth failed to detect several strongly differentially
abundant features in these datasets (e.g the hypothesis test for
Firmicutes results in a p-value of 0.87). This may be due in part to
difficulties in estimating the parameters of their model for our
datasets and further strengthens the case for the design of methods
specifically tuned to the characteristics of metagenomic data. For
cases where a particular taxon had no observations in one
population (e.g. Terasakiella), the methods proposed for SAGE data
seem to perform poorly.
Differentially abundant COGs between mature and infant
human gut microbiomes
Targeted sequencing of the 16S rRNA can only provide an
overview of the diversity within a microbial community but cannot
provide any information about the functional roles of members of
this community. Random shotgun sequencing of environments
can provide a glimpse at the functional complexity encoded in the
Figure 5. ROC curves comparing statistical methods in a simulation study for extreme sparse sampling. Sequences were selected from
a beta-binomial distribution with variable dispersions and group mean proportions p1 and p2. For each set of parameters, we simulated 1000 trials,
500 of which are generated under the null hypothesis (p1=p2), and the remainder are differentially abundant where a*p1=p2. For example, p=0.2
and a=2 indicates features comprising 20% of the population that differ two-fold in abundance between two populations of interest. Parameter
values for p1 and a are shown above each plot.
doi:10.1371/journal.pcbi.1000352.g005
Figure 4. ROC curves comparing statistical methods in a simulation study. Sequences were selected from a beta-binomial distribution with
variable dispersions and group mean proportions p1 and p2. For each set of parameters, we simulated 1000 trials, 500 of which are generated under
the null hypothesis (p1=p2), and the remainder are differentially abundant where a*p1=p2. For example, p=0.2 and a=2 indicates features
comprising 20% of the population that differ two-fold in abundance between two populations of interest. Parameter values for p1 and a are shown
above each plot.
doi:10.1371/journal.pcbi.1000352.g004
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defining the functional capacity of an environment is to map
shotgun sequences to homologous sequences with known function.
This strategy was used by Kurokawa et al. [34] to identify clusters
of orthologous groups (COGs) in the gut microbiomes of 13
individuals, including four unweaned infants. We examined the
COGs determined by this study across all subjects and used
Metastats to discover differentially abundant COGs between
infants and mature (.1 year old) gut microbiomes. This is the first
direct comparison of these two populations as the original study
only compared each population to a reference database to find
enriched gene sets. Due to the high number of features (3868
COGs) tested for this dataset and the limited number of infant
subjects available, our method used the pooling option to compute
p-values (we chose 100 permutations), and subsequently computed
q-values for each feature. Using a threshold of Q#0.05
(controlling the false discovery rate to 5%), we detected 192
COGs that were differentially abundant between these two
populations (see Table 3 for a lisitng of the most abundant COGs
in both mature and infant microbiomes. Full results are presented
as supplementary material in Table S1).
The most abundant enriched COGs in mature subjects included
signal transduction histidine kinase (COG0642), outer membrane
receptor proteins, such as Fe transport (COG1629), and Beta-
galactosidase/beta-glucuronidase (COG3250). These COGs were
also quite abundant in infants, but depleted relative to mature
subjects. Infants maintained enriched COGs related to sugar
transport systems (COG1129) and transcriptional regulation
(COG1475). This over-abundance of sugar transport functions was
alsofound inthe original study,strengthening the hypothesisthat the
unweaned infant gut microbiome is specifically designed for the
digestion of simple sugars found in breast milk. Similarly, the
depletion of Fe transport proteins in infants may be associated with
the low concentration of iron in breast milk relative to cow’s milk
[38]. Despite this low concentration, infant absorption of iron from
breastmilkisremarkablyhigh,andbecomespoorerwheninfantsare
weaned, indicating an alternative mechanism for uptake of this
mineral. The potential for a different mechanism is supported by the
detection of a Ferredoxin-like protein (COG2440) that was 11 times
more abundant in infants than in mature subjects, while Ferredoxin
(COG1145) was significantly enriched in mature subjects.
Table 2. Differentially abundant taxa between lean and obese human gut microflora.
Taxon Obese abundance(%) Lean abundance(%) Metastats p-value Student-t p-value Log-t p-value NB p-value
Phyla
Bacteroidetes 2.90261.067 25.65264.576 0.0002 0.0000 0.0004 0.0000
Firmicutes 89.31862.223 72.83364.812 0.0028 0.0025 0.0030 0.8701
Actinobacteria 4.49061.345 0.44760.179 0.0037 0.0371 0.0004 0.0773
Classes
Bacteroidetes (class) 2.72261.065 25.65264.576 0.0001 0.0000 0.0005 0.0001
Actinobacteria (class) 4.49061.345 0.44760.179 0.0024 0.0371 0.0004 0.1858
Clostridia 84.63362.388 66.90765.799 0.0036 0.0042 0.0052 0.9797
Genera
Syntrophococcus 2.38060.383 0.66660.337 0.0014 0.0077 0.0067 0.4860
Terasakiella 0.000600 . 1 1 5 60.115 0.0016 0.1986 0.9963 0.0166
Ruminococcus 26.27664.454 10.70762.094 0.0023 0.0207 0.0039 0.6639
Marinilabilia 0.01060.010 0.13860.138 0.0024 0.2353 0.0467 0.0011
Collinsella 3.56561.187 0.15460.154 0.0052 0.0451 0.0046 0.6545
Bacteroides 1.84160.963 14.62364.444 0.0056 0.0023 0.0105 0.0012
Paludibacter 0.000600 . 0 9 3 60.069 0.0059 0.0896 0.9963 0.0000
Bryantella 0.46160.051 0.15160.102 0.0065 0.0072 0.0304 0.0487
Desulfovibrio 0.03160.031 0.14560.145 0.0073 0.3390 0.2315 0.0156
For the phylum, class, and genus levels (mean percentage6s.e., p-value#0.01) we successfully re-established the major result of Ley et al., and uncovered a new
difference within Actinobacteria. Both Firmicutes and Actinobacteria have significantly higher relative abundances in obese people, while Bacteroidetes make up a
higher proportion of the gut microbiota in the lean population. Results reveal Clostridia as the primary component of the differential abundance observed within
Firmicutes, and Bacteroidetes and Actinobacteria classes explain the differential abundance observed within the corresponding phyla. Using this p-value threshold, we
expect less than one false positive among these results. The last four columns display the computed p-values for different statistical methods, including Metastats and
the overdispersion methods of Lu et al. (Log-t) and Robinson and Smyth (NB). These results reveal NB and Student’s t-test to be overly-conservative.
doi:10.1371/journal.pcbi.1000352.t002
Table 1. Comparison of false positives found by different
methodologies. Using real metagenomic data, we simulated
features with no differential abundance by randomly dividing
subjects from a single population into two subpopulations.
P# Number of False Positives
Metastats Student-t Log-t NB
0.001 7 4 4 109
0.005 25 25 24 121
0.01 51 52 43 133
We found that for a stringent p-value threshold of 0.001, the negative binomial
model (NB) resulted in a false positive rate 20 times higher than the other
methodologies. The Log-t of Lu et al. resulted in the lowest false positive rate
among the methods tested while Student’s test and Metastats performed
equally well.
doi:10.1371/journal.pcbi.1000352.t001
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A recent study by Dinsdale et al. profiled 87 different
metagenomic shotgun samples (,15 million sequences) using
the SEED platform (http://www.theseed.org) [6] to see if
biogeochemical conditions correlate with metagenome charac-
teristics. We obtained functional profiles from 45 microbial and
40 viral metagenomes analyzed in this study. Within the 26
Table 3. COGs determined to be differentially abundant between infant and mature human gut microbiomes using a q-value
threshold of 0.05.
COG id Description Mature Infant
Metastat q-
value
Mean
abundance (%) stderr
Mean
abundance (%) stderr
COG0205 6-phosphofructokinase 0.0017 0.0001 0.0006 0.0002 0.0313
COG0358 DNA primase (bacterial type) 0.0024 0.0001 0.0008 0.0001 0.0072
COG0507 ATP-dependent exoDNAse (exonuclease V), alpha subunit - helicase
superfamily I member
0.0016 0.0001 0.0008 0.0001 0.0349
COG0526 Thiol-disulfide isomerase and thioredoxins 0.0028 0.0002 0.0014 0.0002 0.0371
COG0621 2-methylthioadenine synthetase 0.0017 0.0001 0.0008 0.0002 0.0450
COG0642 Signal transduction histidine kinase 0.0132 0.0009 0.0070 0.0004 0.0270
COG0667 Predicted oxidoreductases (related to aryl-alcohol dehydrogenases) 0.0012 0.0001 0.0021 0.0001 0.0282
COG0739 Membrane proteins related to metalloendopeptidases 0.0024 0.0001 0.0006 0.0001 0.0072
COG0745 Response regulators consisting of a CheY-like receiver domain and
a winged-helix DNA-binding domain
0.0076 0.0003 0.0051 0.0004 0.0352
COG0747 ABC-type dipeptide transport system, periplasmic component 0.0011 0.0001 0.0027 0.0003 0.0352
COG1113 Gamma-aminobutyrate permease and related permeases 0.0002 0.0001 0.0018 0.0003 0.0349
COG1129 ABC-type sugar transport system, ATPase component 0.0013 0.0001 0.0028 0.0003 0.0492
COG1145 Ferredoxin 0.0017 0.0001 0.0005 0.0002 0.0217
COG1196 Chromosome segregation ATPases 0.0017 0.0001 0.0007 0.0001 0.0108
COG1249 Pyruvate/2-oxoglutarate dehydrogenase complex, dihydrolipoamide
dehydrogenase (E3) component, and related enzymes
0.0006 0.0001 0.0011 0.0001 0.0349
COG1263 Phosphotransferase system IIC components, glucose/maltose/N-
acetylglucosamine-specific
0.0012 0.0001 0.0031 0.0003 0.0313
COG1475 Predicted transcriptional regulators 0.0025 0.0002 0.0014 0.0002 0.0435
COG1595 DNA-directed RNA polymerase specialized sigma subunit, sigma24 homolog 0.0053 0.0004 0.0013 0.0003 0.0206
COG1609 Transcriptional regulators 0.0030 0.0002 0.0092 0.0013 0.0424
COG1629 Outer membrane receptor proteins, mostly Fe transport 0.0120 0.0016 0.0013 0.0007 0.0313
COG1762 Phosphotransferase system mannitol/fructose-specific IIA domain (Ntr-type) 0.0004 0.0001 0.0017 0.0002 0.0293
COG1961 Site-specific recombinases, DNA invertase Pin homologs 0.0059 0.0004 0.0018 0.0006 0.0345
COG2204 Response regulator containing CheY-like receiver, AAA-type ATPase, and
DNA-binding domains
0.0019 0.0002 0.0005 0.0002 0.0421
COG2244 Membrane protein involved in the export of O-antigen and teichoic acid 0.0019 0.0001 0.0009 0.0001 0.0229
COG2376 Dihydroxyacetone kinase 0.0002 0 0.0009 0.0001 0.0278
COG2440 Ferredoxin-like protein 0 0 0.0002 0 0.0394
COG2893 Phosphotransferase system, mannose/fructose-specific component IIA 0.0003 0.0001 0.0011 0.0001 0.0352
COG3250 Beta-galactosidase/beta-glucuronidase 0.0056 0.0004 0.0023 0.0006 0.0435
COG3451 Type IV secretory pathway, VirB4 components 0.0033 0.0001 0.0009 0.0003 0.0157
COG3505 Type IV secretory pathway, VirD4 components 0.0029 0.0001 0.0010 0.0003 0.0278
COG3525 N-acetyl-beta-hexosaminidase 0.0016 0.0002 0.0004 0.0001 0.0352
COG3537 Putative alpha-1,2-mannosidase 0.0020 0.0003 0.0002 0.0002 0.0352
COG3711 Transcriptional antiterminator 0.0004 0.0001 0.0020 0.0003 0.0339
COG3712 Fe2+-dicitrate sensor, membrane component 0.0023 0.0003 0 0 0.0280
COG4206 Outer membrane cobalamin receptor protein 0.0021 0.0003 0.0003 0.0001 0.0313
COG4771 Outer membrane receptor for ferrienterochelin and colicins 0.0039 0.0005 0.0006 0.0003 0.0366
Using this threshold we expect less than 10 false positives in this data-set. The table presents the 25 most abundant COGs from the mature and infant microbiomes,
sorted by their abundance level in the mature population. Full results are available as supplementary material.
doi:10.1371/journal.pcbi.1000352.t003
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al. study, we found 13 to be significantly different (P#0.05)
between the microbial and viral samples (Table 4). Subsystems
for RNA and DNA metabolism were significantly more
abundant in viral metagenomes, while nitrogen metabolism,
membrane transport, and carbohydrates were all enriched in
microbial communities. The high levels of RNA and DNA
metabolism in viral metagenomes illustrate their need for a self-
sufficient source of nucleotides. Though the differences described
by the original study did not include estimates of significance,
our results largely agreed with the authors’ qualitative conclu-
sions. However, due to the continuously updated annotations in
the SEED database since the initial publication, we found several
differences between our results and those originally reported. In
particular we found virulence subsystems to be less abundant
overall than previously reported, and could not find any
significant differences in their abundance between the microbial
and viral metagenomes.
Discussion
We have presented a statistical method for handling frequency
data to detect differentially abundant features between two
populations. This method can be applied to the analysis of any
count data generated through molecular methods, including
random shotgun sequencing of environmental samples, targeted
sequencing of specific genes in a metagenomic sample, digital gene
expression surveys (e.g. SAGE [29]), or even whole-genome
shotgun data (e.g. comparing the depth of sequencing coverage
across assembled genes). Comparisons on both simulated and real
dataset indicate that the performance of our software is
comparable to other statistical approaches when applied to well-
sampled datasets, and outperforms these methods on sparse data.
Ourmethodcanalsobegeneralizedtoexperimentswithmorethan
two populations by substituting the t-test with a one-way ANOVA
test. Furthermore, if only a single sample from each treatment is
available, a chi-squared test can be used instead of the t-test. [27].
In the coming years metagenomic studies will increasingly be
applied in a clinical setting, requiring new algorithms and software
tools to be developed that can exploit data from hundreds to
thousands of patients. The methods described above represent an
initial step in this direction by providing a robust and rigorous
statistical method for identifying organisms and other features
whose differential abundance correlates with disease. These
methods, associated source code, and a web interface to our tools
are freely available at http://metastats.cbcb.umd.edu.
Supporting Information
Table S1 Comparison of COG composition between mature
and infant microbiomes. The relative abundance of each COG is
presented together with significance values (likelihood that
difference in abundance is due to chance alone)computed using
several statistical procedure: metastats (p and q values), student’s t-
test, log linear model, and negative binomial model.
Found at: doi:10.1371/journal.pcbi.1000352.s001 (0.95 MB XLS)
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